Status: Recruiting
Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia
The goal of this clinical trial is to evaluate the safety and efficacy of EXV-802 and EXV-801 in treatment of agitation in participants with Alzheimer's Disease dementia.
Participants needed: 300
Trial details
Phase: Phase 2, Phase 3Age: 55-90Biological sex: AllType: InterventionalSponsor: Exciva GmbHUpdated: Jun 5, 2026Locations: 49
Eligibility criteria
The participant is an adult male or female between the ages of 55 to 90 years in... [+4]
The participant has a confirmed primary diagnosis of a dementia-related disease... [+3]